Carcinogenesis, Vol. 23, No. 2, 351-358,
February 2002
© 2002 Oxford University Press
CARCINOGENESIS |
Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells
Third Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-8566, Japan
We investigated the effect of transfection with connexin (Cx) 26 gene on the malignant potential of PLC/PRF/5 hepatoma cells, observing changes in their morphological features, alpha-fetoprotein (AFP) expression, cell proliferation and apoptosis in vitro, and their tumor growth in vivo. Fluorescence-activated cell sorting (FACS) analysis showed that 10.6% of PLC/PRF/5 hepatoma cells transfected with Cx26 cDNA expressed excessive Cx26, and the spread of lucifer yellow was wider in the colony of stable transfectants (PLC/Cx26) after its microinjection than in control. Nucleo-cytoplasmic (N/C) ratio was significantly lower in PLC/Cx26 (P < 0.0001). Cell proliferation assay showed significantly lower numbers in PLC/Cx26 on day 10 after seeding than in control (P = 0.0039), and AFP level /105cells was significantly lower in medium of PLC/Cx26 (P = 0.0039). The number of proliferating cell nuclear antigen (PCNA)-positive cells was less in PLC/Cx26 in vitro than in control (P = 0.0039), and single-stranded DNA (ssDNA)-positive cells were more abundant in the colony of PLC/Cx26 (P = 0.029). Tumor volume in SCID mice was significantly smaller in the group of PLC/Cx26 than in the control (P < 0.01) throughout the observation period, and tumor weight of PLC/Cx26 was significantly lower (P = 0.0019) week 9 after inoculation. Transfection with Cx26 cDNA inhibited dedifferentiation, suppressed cell proliferation, and apoptosis was induced. Tumor growth of PLC/Cx26 was retarded. These findings suggest that transfection with Cx26 gene into human hepatoma cells reduces their malignant potential.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Ezumi, H. Yamamoto, K. Murata, M. Higashiyama, B. Damdinsuren, Y. Nakamura, N. Kyo, J. Okami, C. Y. Ngan, I. Takemasa, et al. Aberrant Expression of Connexin 26 Is Associated with Lung Metastasis of Colorectal Cancer Clin. Cancer Res., February 1, 2008; 14(3): 677 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. Capurro, Y.-Y. Xiang, C. Lobe, and J. Filmus Glypican-3 Promotes the Growth of Hepatocellular Carcinoma by Stimulating Canonical Wnt Signaling Cancer Res., July 15, 2005; 65(14): 6245 - 6254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-T. Chen, Y.-W. Cheng, M.-C. Chou, T. Sen-Lin, W.-W. Lai, W. L. Ho, and H. Lee The Correlation between Aberrant Connexin 43 mRNA Expression Induced by Promoter Methylation and Nodal Micrometastasis in Non-Small Cell Lung Cancer Clin. Cancer Res., September 15, 2003; 9(11): 4200 - 4204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Leithe, V. Cruciani, T. Sanner, S.-O. Mikalsen, and E. Rivedal Recovery of gap junctional intercellular communication after phorbol ester treatment requires proteasomal degradation of protein kinase C Carcinogenesis, July 1, 2003; 24(7): 1239 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Chipman, A. Mally, and G. O. Edwards Disruption of Gap Junctions in Toxicity and Carcinogenicity Toxicol. Sci., February 1, 2003; 71(2): 146 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Su, L. G. Guidotti, J. P. Pezacki, F. V. Chisari, and P. G. Schultz Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice PNAS, August 20, 2002; 99(17): 11181 - 11186. [Abstract] [Full Text] [PDF]
|
|